Ellence (Epirubicin hydrochloride) Drug Information: Medication Guide and Patient Information

Pill Identifier Search

May 27, 2012

Ellence

Breast Cancer »

Breast cancer facts

Breast cancer is the most common cancer among American women.
One in every eight women in the United States develops breast cancer.
There are many types of breast cancer that differ in their capability of spreading (metastasize) to other body tissues.
The causes of breast cancer are not yet fully known although a number of risk factors have been identified.
There are many different types of breast cancer.
Breast cancer is diagnosed with physician and self-examination of the breasts, mammography, ultrasound testing, and biopsy.
Treatment of breast cancer depends on the type of cancer and its stage (the extent of spread in the body).

According to the American Cancer society:

Over 200,000 new cases of invasive breast cancer are diagnosed each year.
Nearly 40,000 women will die of breast cancer in 2011.
There are over 2...

Read the Breast Cancer article »

« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
Next »

Ellence

Breast Cancer Slideshow Pictures

Take the Breast Cancer Quiz

Disease Prevention in Women Slideshow Pictures

font size

PATIENT INFORMATION

Inform patients of the expected adverse effects of ELLENCE, including gastrointestinal symptoms (nausea, vomiting, diarrhea, and stomatitis), alopecia and potential neutropenic complications.

Patients should understand that there is a risk of irreversible myocardial damage associated with treatment with ELLENCE, as well as a risk of treatment-related leukemia.

Patients should consult their physician if vomiting, dehydration, fever, evidence of infection, symptoms of CHF, or injection-site pain occurs following therapy with ELLENCE.

Advise patients that their urine may appear red for 1 to 2 days after administration of ELLENCE and that they should not be alarmed.

Because ELLENCE may induce chromosomal damage in sperm, advise men undergoing treatment with ELLENCE to use effective contraceptive methods. Women treated with ELLENCE may develop irreversible amenorrhea, or premature menopause.

Last reviewed on RxList: 9/22/2011
This monograph has been modified to include the generic and brand name in many instances.